STERIS market cap STE
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Nov 3, 2026
- $22.7B
- Highest close in our data
- $26.4B
- Jan 2026
STERIS is worth $22.7B at the close on Nov 3, 2026, at $231.42 a share.
That is down 13% over the last year and up 1% over five years.
Its highest close in our data was $26.4B in Jan 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $22.8B | $19.8B | $26.4B | −9% |
| 2025 | $25.1B | $20.1B | $26.1B | +22% |
| 2024 | $20.5B | $19.7B | $24.1B | −5% |
| 2023 | $21.7B | $17.5B | $22.9B | +18% |
| 2022 | $18.4B | $16.3B | $24.9B | −24% |
| 2021 | $24.3B | $14.9B | $24.3B | +51% |
| 2020 | $16.2B | $9.8B | $16.7B | +26% |
| 2019 | $12.9B | $11.3B | $13.1B | n/a |
Against its peers
Companies in Healthcare nearest STERIS' size, closest first, today.
| Company | Market cap |
|---|---|
| STESTERIS | $22.7B |
| THCTenet Healthcare | $21.5B |
| INCYIncyte | $24.3B |
| ALNYAlnylam Pharmaceuticals | $21.2B |
| UTHRUnited Therapeutics | $25.9B |
| DGXQuest Diagnostics | $27.5B |
| ZBHZimmer Biomet | $18.6B |
| MEDPMedpace | $18.1B |
| WSTWest Pharmaceutical Services | $28.9B |
| LHLabcorp | $28.9B |
| EXELExelixis | $17.4B |
| Peer median | $22.9B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on STERIS
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.